Home LiteratureArticle Details
PMID: 9122234 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM

Abstract

Genetically obese fatty/fatty rats and obese/obese mice exhibit increased sensitivity to endotoxin hepatotoxicity, quickly developing steatohepatitis after exposure to low doses of lipopolysaccharide (LPS). Among obese animals, females are more sensitive to endotoxin liver injury than males. LPS induction of tumor necrosis factor alpha (TNF alpha), the proven affecter of endotoxin liver injury, is no greater in the livers, white adipose tissues, or sera of obese animals than in those of lean controls. Indeed, the lowest serum concentrations of TNF occur in female obese rodents, which exhibit the most endotoxin-induced liver injury. Several cytokines that modulate the biological activity of TNF are regulated abnormally in the livers of obese animals. After exposure to LPS, mRNA of interferon gamma, which sensitizes hepatocytes to TNF toxicity, is overexpressed, and mRNA levels of interleukin 10, a TNF inhibitor, are decreased. The phagocytic activity of liver macrophages and the hepatic expression of a gene encoding a macrophage-specific receptor are also decreased in obesity. This new animal model of obesity-associated liver disease demonstrates that hepatic macrophage dysfunction occurs in obesity and suggests that this might promote steatohepatitis by sensitizing hepatocytes to endotoxin.

MeSH Terms
Animals Escherichia coli Fatty Liver/pathology,physiopathology Female Hepatitis, Animal/pathology,physiopathology Kupffer Cells/pathology,physiology Lipopolysaccharides/toxicity Liver/drug effects,metabolism,pathology Male Mice Mice, Obese Obesity/genetics,pathology,physiopathology Polymerase Chain Reaction Rats Rats, Zucker Sex Characteristics Time Factors Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
Lipopolysaccharides Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yang S Q
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Lin H Z
Lane M D
Clemens M
Diehl A M
References (48)
48 references, click to expand
  1. The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats.
    Hepatology. 1994 Aug;20(2):461-74 PMID: 8045508
  2. Nonalcoholic steatohepatitis: a study of 49 patients.
    Hum Pathol. 1989 Jun;20(6):594-8 PMID: 2656500
  3. Nonalcoholic steatohepatitis: an expanded clinical entity.
    Gastroenterology. 1994 Oct;107(4):1103-9 PMID: 7523217
  4. Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages.
    J Hepatol. 1994 Jun;20(6):811-8 PMID: 7930483
  5. Control of tumor necrosis factor gene expression.
    Crit Rev Eukaryot Gene Expr. 1994;4(2-3):323-44 PMID: 7881165
  6. Augmented production of tumor necrosis factor-alpha in obese mice.
    Clin Immunol Immunopathol. 1995 Apr;75(1):51-6 PMID: 7882592
  7. Immunotoxicology of host-response-mediated experimental liver injury.
    J Hepatol. 1994 Nov;21(5):890-903 PMID: 7890909
  8. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
    J Clin Invest. 1995 May;95(5):2111-9 PMID: 7738178
  9. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.
    Gastroenterology. 1995 Jun;108(6):1849-54 PMID: 7768392
  10. Role of proinflammatory cytokines in acetaminophen hepatotoxicity.
    Toxicol Appl Pharmacol. 1995 Jul;133(1):43-52 PMID: 7597709
  11. Effects of the obese gene product on body weight regulation in ob/ob mice.
    Science. 1995 Jul 28;269(5223):540-3 PMID: 7624776
  12. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
    Hepatology. 1990 Jan;11(1):74-80 PMID: 2295475
  13. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.
    J Clin Invest. 1990 Jun;85(6):1936-43 PMID: 2161433
  14. Biologically active products of stimulated liver macrophages (Kupffer cells).
    Eur J Biochem. 1990 Sep 11;192(2):245-61 PMID: 2170121
  15. Liver pathology in morbidly obese patients with and without diabetes.
    Am J Gastroenterol. 1990 Oct;85(10):1349-55 PMID: 2220728
  16. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
    Hepatology. 1990 Nov;12(5):1106-10 PMID: 2227807
  17. Bacterial endotoxins and the liver.
    Lab Invest. 1990 Dec;63(6):733-41 PMID: 2255181
  18. Structure of the gene for a carbohydrate-binding receptor unique to rat kupffer cells.
    J Biol Chem. 1991 Jan 25;266(3):1850-7 PMID: 1846367
  19. Lead enhances lipopolysaccharide and tumor necrosis factor liver injury.
    J Lab Clin Med. 1991 Mar;117(3):202-8 PMID: 1672139
  20. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10535-9 PMID: 1660140
  21. Tumor necrosis factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin hypersensitivity in C57BL/6J mice congenic at the Ah locus.
    Toxicol Appl Pharmacol. 1991 Dec;111(3):422-31 PMID: 1660630
  22. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes.
    Arch Biochem Biophys. 1992 Apr;294(1):223-9 PMID: 1550349
  23. The pathophysiology of tumor necrosis factors.
    Annu Rev Immunol. 1992;10:411-52 PMID: 1590993
  24. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    J Leukoc Biol. 1993 Jul;54(1):23-9 PMID: 8336076
  25. Cytokines and alcoholic liver disease.
    Semin Liver Dis. 1993 May;13(2):170-82 PMID: 8337603
  26. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF.
    EMBO J. 1993 Aug;12(8):3095-104 PMID: 8344250
  27. Tumor necrosis factor, other cytokines and disease.
    Annu Rev Cell Biol. 1993;9:317-43 PMID: 8280464
  28. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.
    Nature. 1994 Jul 21;370(6486):218-20 PMID: 8028669
  29. Mechanism of suppression of cell-mediated immunity by measles virus.
    Science. 1996 Jul 12;273(5272):228-31 PMID: 8662504
  30. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats.
    Am J Physiol. 1996 Jun;270(6 Pt 1):G909-18 PMID: 8764196
  31. Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines.
    Shock. 1996 Oct;6(4):243-7 PMID: 8902939
  32. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature.
    Medicine (Baltimore). 1962 Sep;41:249-76 PMID: 14463641
  33. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.
    Science. 1995 Jul 28;269(5223):546-9 PMID: 7624778
  34. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.
    Science. 1996 Feb 2;271(5249):665-8 PMID: 8571133
  35. Defective STAT signaling by the leptin receptor in diabetic mice.
    Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6231-5 PMID: 8692797
  36. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes.
    J Biol Chem. 1996 Jul 26;271(30):17974-8 PMID: 8663327
  37. Natural history of alcoholic hepatitis. 3. Histological changes.
    Gastroenterology. 1972 Dec;63(6):1026-35 PMID: 4639358
  38. Fatty liver hepatitis and cirrhosis in obese patients.
    Am J Med. 1979 Nov;67(5):811-6 PMID: 507094
  39. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
    Mayo Clin Proc. 1980 Jul;55(7):434-8 PMID: 7382552
  40. Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: a prospective study.
    Hepatology. 1981 Mar-Apr;1(2):161-7 PMID: 7286895
  41. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement.
    Ann Intern Med. 1985 Jul;103(1):147-51 PMID: 4003973
  42. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage.
    J Hepatol. 1986;2(1):33-42 PMID: 3950362
  43. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  44. The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model.
    Hepatology. 1987 Nov-Dec;7(6):1184-8 PMID: 3679086
  45. Pattern of progression in liver injury following jejunoileal bypass for morbid obesity.
    Liver. 1987 Oct;7(5):271-6 PMID: 3695814
  46. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.
    Gastroenterology. 1988 Oct;95(4):1056-62 PMID: 3410220
  47. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Biochem Pharmacol. 1989 Feb 15;38(4):627-31 PMID: 2465008
  48. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest.
    J Immunol. 1994 Aug 15;153(4):1778-88 PMID: 8046244
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-03-18
Pages
2557-62
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC20127
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com